Archived News Stories
16 Oct 2007 | 3M ESPE launch Aloclair spray in the US |
04 Oct 2007 | Sinclair presents data on pipeline technologies for acne, psoriasis, corrective dermatology |
27 Sep 2007 | Sinclair Pharma plc preliminary results |
27 Sep 2007 | New distribution deal for Sebclair in the US, with Dr Reddy\'s Laboratories |
25 Sep 2007 | Atopiclair and Xclair launched in UK |
12 Sep 2007 | Sinclair Pharma plc announces first regulatory filing in Japan
and first approval in Australia
|
14 Aug 2007 | Update on status of Decapinol in US, and update to recent trading statement |
24 Jul 2007 | Pre-close statement |
12 Jun 2007 | Sinclair R&D and Corporate Update Day |
05 Jun 2007 | Atopiclair launched in key EU territores |
24 May 2007 | Sinclair acquires Fazol brand |
30 Apr 2007 | Atopiclair sales in US hit $10m |
16 Apr 2007 | Principales caractéristiques de l’admission des actions Sinclair Pharma PLC aux négociations sur l’Eurolist d’Euronext Paris |
16 Apr 2007 | Sinclair move to the Offical List |
12 Apr 2007 | Proposed move to Official List |
26 Mar 2007 | Interim results: 145% growth in the first half |
20 Mar 2007 | Further Decapinol approvals and clinical data |
15 Mar 2007 | Sinclair announces intention to migrate to Official List in April, and seek secondary listing on Eurolist |
21 Feb 2007 | Dexcel announced as new UK Aloclair distributor |
29 Jan 2007 | Sinclair announces first China deal |
23 Jan 2007 | Pre-close statement: 143% sales growth, strong order book, further integration |
16 Jan 2007 | Arlevert deal launches UK Product Fostering concept |
14 Dec 2006 | Sinclair signs deal with OMNI Preventative Care, part of 3M ESPE, for Aloclair spray in US |
29 Nov 2006 | Sinclair acquires peptide p1025 for dental caries |
22 Nov 2006 | Positive trial results for Atopiclair |
16 Nov 2006 | Sinclair presenting at Piper Jaffray conference, New York, 28th November 2006 |
15 Nov 2006 | AGM Statement |
02 Nov 2006 | Sebclair gains US approval |
02 Oct 2006 | Sinclair signs Atopiclair agreement with Intendis for eight major territories |
27 Sep 2006 | Sinclair acquires UK sales and marketing company Ashbourne Pharmaceuticals Ltd |
26 Sep 2006 | Sinclair delivers strong growth. Sinclair announces preliminary results |
20 Sep 2006 | Sinclair announces positive results of paediatric atopic dermatitis study for Atopiclair |
27 Jul 2006 | Trading Update for the year ended 30 June 2006 |
12 Jul 2006 | Sinclair Announces Ophthalmology Approval |
06 Jul 2006 | Sinclair Appoints Danilo Casadei Massari as VP, Corporate Development |
29 Jun 2006 | Sinclair Pharma Plc licenses US rights for lead product Decapinol |
15 Jun 2006 | Sinclair R&D day: Sinclair announces R&D update, Sebclair clinical trial results, new agreements |
10 Apr 2006 | EGM Results: share placement for acquisition of Groupe CS Dermatologie |
16 Mar 2006 | Sinclair Wins 2006 Oral & Dental Care Product of the Year Award |
13 Mar 2006 | Interim Results |
13 Mar 2006 | Atopiclair in USA Expanded and New IP Product for Onychomycosis |
13 Mar 2006 | Proposed Acquisition |
13 Mar 2006 | IFRS Transition Support Document |
25 Jan 2006 | Sinclair Pharma Strengthens Board. |
18 Jan 2006 | Pre-Close Period Trading Update |
12 Jan 2006 | Change of Broker |
29 Nov 2005 | Institutional placing raises approximately £7.4 million |
28 Nov 2005 | AGM Statement 28 11 05 |
06 Oct 2005 | Preliminary results for the year ended 30 June 2005 |
06 Oct 2005 | New Atopiclair™ and Decapinol® Distribution Deals
FDA extend Decapinol® label |
09 Sep 2005 | Appointment of New Advisers |
06 Sep 2005 | Atopiclair Italy Launch |
22 Aug 2005 | Sinclair Pharma Signs Aloclair® Marketing & Sales Agreement with John O.Butler Mexico |
26 Jul 2005 | Three New Sales and Marketing Agreements. Sebclair in US and Xclair and Salinum in Greece |
12 Jul 2005 | Sinclair Pharma plc obtains EU registration for two new oral health products - Decapinol Toothpaste and Decapinol Gel |
07 Jul 2005 | Xclair Licensing Agreements in Portugal and Brazil |
29 Jun 2005 | New licensing agreements in USA, Israel, Colombia |
29 Jun 2005 | Analyst R&D briefing |
21 Jun 2005 | Sinclair Pharma plc announces positive results:
US multicentre trial confirms efficacy of Atopiclair™ in atopic dermatitis
Atopiclair™ launched in the US |
31 May 2005 | Sinclair Announces Launch of Decapinol®
Four new licensing agreements - SST™, Salinum™ & Aloclair® |
25 Apr 2005 | New distribution agreements for Atopiclair and Aloclair |
25 Apr 2005 | Derek Williams appointed to Board |
19 Apr 2005 | FDA Press release: "FDA Approves New Oral Rinse to Help Treat Gingivitis" |
19 Apr 2005 | Decapinol gains US (FDA) approval |
04 Apr 2005 | Sebclair gains EU approval |
31 Mar 2005 | Sinclair Pharma Plc Interim results |
21 Feb 2005 | Aloclair (Rincinol) distribution expands in US |
17 Feb 2005 | Aloclair territories expand, Atopiclair in EU |
08 Feb 2005 | Aloclair approved by UK Dental Health Foundation |
28 Jan 2005 | Pre-Close Statement 28 01 05 |
24 Jan 2005 | Sinclair Pharma plc Aloclair Spray receives FDA 510(k) approval |
04 Jan 2005 | Sinclair Pharma plc Licenses Decapinol to Dompe in Italy |
22 Dec 2004 | Sinclair Pharma acquires Euroderm RDC SpA |
21 Dec 2004 | Sinclair Pharma plc Licenses Atopiclair in the US |
14 Oct 2004 | Sinclair Pharma plc Preliminary results |
12 Jul 2004 | Grahame Cook appointed as Non Executive Director |
07 Jul 2004 | Sinclair Pharma plc announces new product T-Go, and its EU registration |
01 Jul 2004 | Decapinol approved in EU
Aloclair gel approved in US
Year End trading update |
16 Jun 2004 | Sinclair Pharma plc files for Decapinol 510(k) approval in the USA |
10 Jun 2004 | Atopiclair shows positive results in contact dermatitis study |
28 Apr 2004 | Decapinol recognised as medical device by FDA |
26 Mar 2004 | Sinclair Pharma plc interim results |
03 Feb 2004 | Atopiclair and Xclair gain EU approval |
04 Dec 2003 | Sinclair Pharma plc admission to AIM |
21 Nov 2003 | Sinclair Pharma plc announces intention to float |
